Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Lebrikizumab in Uncontrolled Asthma on Inhaled Corticosteroids and Second Controller
2011-004205-24Phase 3Terminated
- Sponsor
- Roche
- Start
- Apr 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Lebrikizumab arm with Placebo arm (2 arms). Primary endpoint: Rate of asthma exacerbations. Started Apr 2012; status: terminated.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-004205-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004205-24.